SEC Form EFFECT filed by SELLAS Life Sciences Group, Inc.
$SLS
Biotechnology: Pharmaceutical Preparations
Health Care
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 29, 2021 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||